In vitro characterization of the optichamber diamond valved holding chamber

Journal of Aerosol Medicine and Pulmonary Drug Delivery

Volumn 27, Issue SUPPL. 1, 2014, Pages

  Hatley, Ross H M ^a   Von Hollen, Dirk ^a   Sandell, Dennis ^b   Slator, Lois ^a  

^a PHILIPS RESEARCH LABORATORIES   (Germany)

^b S5 Consulting   (Sweden)

Author keywords

aerodynamic particle size distribution; flow rate; in vitro equivalence; pMDI; valved holding chamber

Indexed keywords

BECLOMETASONE DIPROPIONATE; PROCATEROL; SALBUTAMOL; AEROSOL; BECLOMETASONE;

AERODYNAMIC PARTICLE SIZE DISTRIBUTION; AEROSOL; ARTICLE; DRUG DELIVERY DEVICE; DRUG DELIVERY SYSTEM; DRUG DISTRIBUTION; DRUG FORMULATION; DRUG SOLUTION; DYNAMICS; EQUIPMENT DESIGN; FLOW RATE; IN VITRO STUDY; MEDICAL NEBULIZER; METERED DOSE INHALER; PARTICLE SIZE; PRESSURIZED METERED DOSE INHALER; SUSPENSION; VALVED HOLDING CHAMBER; CHEMISTRY; COMPARATIVE STUDY; DEVICES; FLOW KINETICS; HUMAN; INHALATION; INHALATIONAL DRUG ADMINISTRATION; MEDICINAL CHEMISTRY; PRESSURE; TIME;

ADMINISTRATION, INHALATION; AEROSOLS; ALBUTEROL; BECLOMETHASONE; CHEMISTRY, PHARMACEUTICAL; DRUG DELIVERY SYSTEMS; EQUIPMENT DESIGN; HUMANS; INHALATION; METERED DOSE INHALERS; PARTICLE SIZE; PRESSURE; RHEOLOGY; TIME FACTORS;

EID: 84904796452     PISSN: 19412711     EISSN: 19412703     Source Type: Journal    
DOI: 10.1089/jamp.2013.1067     Document Type: Article

References (15)

1. NikanDer K, Nicholls C, Denyer J, and Pritchard J: The evolution of spacers and valved holding chambers. J Aerosol Med Pulm Drug Deliv. 2014;27:S-4-S-23.
2. Foss SA, and Keppel JW: In vitro testing of MDI spacers: a technique for measuring respirable dose output with actuation in-phase or out-of-phase with inhalation. Respir Care. 1999;44:1474-1485. (Pubitemid 30014146)
3. Roller CM, Zhang G, Troedson RG, Leach CL, Le Souëf PN, and Devadason SG: Spacer inhalation technique and Deposition of extrafine aerosol in asthmatic children. Eur Respir J. 2007;29:299-306. (Pubitemid 46231907)
4. Devadason SG, Huang T, Walker S, Troedson R, and Le Souëf PN: Distribution of technetium-99m-labelled QVAR Delivered using an Autohaler Device in children. Eur Respir J. 2003;21:1007-1011. (Pubitemid 36675618)
5. Rahmatalla MF, Zuberbuhler P, Lange C, and Finlay W: In vitro effect of a holding chamber on the mouth-throat Deposition of QVAR- (hydrofluoroalkane- beclomethasone dipropionate). J Aerosol Med. 2002;15:379-385. (Pubitemid 36105902)
6. Newman SP, Millar AB, Lennard-Jones TR, Morén F, and Clarke SW: Improvement of pressurised aerosol De-position with Nebuhaler spacer Device. Thorax. 1984;39: 935-941. (Pubitemid 15211833)
7. Holzner PM, and Muller BW: An in vitro evaluation of various spacer Devices for metered-dose inhalers using the Twin Impinger. Int J Pharm. 1994;106:69-75. (Pubitemid 24110066)
8. Chew NY, and Chan HK: The effect of spacers on the Delivery of metered dose aerosols of nedocromil sodium and disodium cromoglycate. Int J Pharm. 2000;200:87-92. (Pubitemid 30177253)
9. Mitchell JP, Coppolo DC, and Nagel MW: Electrostatics and inhaled medications: influence on Delivery via pressurized metered-dose inhalers and add-on Devices. Respir Care. 2007;52:283-300.
10. British Standards Institution: BS EN 13544-1:2007 + A1:200: Respiratory therapy equipment. Nebulizing systems and their components. British Standards Institution, London; 2007.
11. European Medicines Agency/Committee for Medicinal Products for Human Use (CHMP): GuiDeline on the requirements for clinical documentation for orally inhaled products (OIP) including the requirements for Demonstration of therapeutic equivalence between two inhaled products for use in the treatment of asthma and chronic obstructive pulmonary disease (COPD) in adults and for use in the treatment of asthma in children and adolescents. European Medicines Agency, London, 22 January 2009. Doc. Ref. CPMP/EWP/4151/00 Rev. 1.
12. Slator L, Von Hollen D, SanDell D, and Hatley RHM: In vitro comparison of the effect of inhalation Delay and flow rate on the emitted dose from three valved holding chambers. J Aerosol Med Pulm Drug Deliv. 2014;27:S-37-S-43.
13. Leach CL, and Collis GL: A pilot study to assess lung Deposition of HFA beclomethasone and CFC-beclomethasone from a pressurized metered dose inhaler with and without add-on spacers, and using varying breathhold times. J Aerosol Med Pulm Drug Deliv. 2010;23:355-361.
14. Newman SP, Pavia D, Garland N, and Clarke SW: Effects of various inhalation moDes on the Deposition of radioactive pressurized aerosols. Eur J Respir Dis. 1982;63(Suppl 119):57-65. (Pubitemid 12060356)
15. Shemirani FM, Hoe S, Lewis D, Church T, Vehrigh R, and Finlay W: In vitro investigation of the effect of ambient humidity on regional Delivered dose with solution and suspension MDIs. J Aerosol Med Pulm Drug Deliv. 2013;26:215-222.